Anterix Inc. ATEX
81.42
0.09
0.11%
as of 25 Sep
- Market cap
- $1.6B
- P/E
- 23.2×
Follow ATEX
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
29.33 | 7.87 | 5.01 | 4.19 |
+8 more quarters Free account |
P/S ratio |
279.04 | 109.78 | 68.75 | 67.71 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
960.74 | 45.99 | (49.30) | 285.76 | |
P/B ratio |
6.87 | 2.72 | 1.73 | 1.67 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
262.89 | 94.98 | 64.16 | 61.51 | |
EV/EBITDA |
25.84 | 6.54 | 4.54 | 3.64 | |
EV/Operating CF |
173.06 | 112.04 | (14.33) | (14.02) | |
EV/FCF |
(95.78) | (28.41) | (7.33) | (7.22) | |
Quick Ratio |
4.13 | 3.03 | 1.06 | 1.35 | |
Current Ratio |
4.85 | 3.33 | 1.39 | 1.70 | |
Net Debt/EBITDA |
800.07 | (4.94) | 3.30 | (0.64) | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.02 | 0.02 | 0.02 | 0.02 | |
Operating CF/Net income |
8.52 | 0.84 | 1.25 | 0.03 | |
Capex/Depreciation |
(66.72) | (71.79) | (25.60) | (99.11) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
62.31% | 64.71% | 70.18% | 78.09% | |
Selling, General and Administrative Expense of Revenue |
589.12% | 565.83% | 641.77% | 634.47% | |
Intangible Assets out of Total Assets |
0.68 | 0.73 | 0.86 | 0.84 | |
Share Based Compensation of Revenue |
167.62% | 137.74% | 140.81% | 189.88% | |
Graham Net Nets |
(0.03) | (0.12) | (0.32) | (0.30) | |
Graham Number |
34.39 | 39.14 | 35.20 | 38.49 | |
Earnings Yield |
3.41% | 12.70% | 19.97% | 23.85% | |
Free Cash Flow Yield |
(0.98%) | (3.05%) | (12.73%) | (12.58%) | |
Revenue per Share |
0.10 | 0.10 | 0.08 | 0.08 | |
Operating CF per Share |
0.11 | 0.83 | (0.44) | 0.08 | |
Capex per Share |
(0.35) | (0.40) | (0.14) | (0.71) | |
Free Cash Flow per Share |
(0.25) | 0.43 | (0.59) | (0.63) | |
Cash per Share |
6.08 | 5.27 | 1.58 | 2.09 | |
Shareholders Equity per Share |
14.97 | 14.04 | 12.63 | 12.86 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
14.97 | 14.04 | 12.63 | 12.86 | |
Free Cash Flow |
(4.69) | 8.13 | (10.93) | (11.78) | |
Working Capital |
121.53 | 83.99 | 14.05 | 24.18 | |
Capital Expenditures |
(6.74) | (7.39) | (2.66) | (13.18) | |
Net Current Asset Value |
(59.05) | (82.90) | (130.99) | (121.22) | |
EV/EBIT |
26.00 | 6.57 | 4.56 | 3.66 | |
Capex to Sales |
3.44 | 3.78 | 1.69 | 8.49 | |
Net Profit Margin |
12.26% | 945.86% | (419.64%) | 3,449.48% | |
Price to Operating Income |
27.59 | 7.60 | 4.89 | 4.03 | |
| Other line items | |||||
Average Receivables |
9.80 | 10.34 | 8.42 | 9.81 | |
Average Payables |
9.27 | 12.05 | 11.95 | 10.95 | |
Average Assets |
428.75 | 399.16 | 371.84 | 368.81 | |
Average Common Equity |
235.28 | 209.46 | 190.35 | 189.71 |
Columns are period end dates